85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks

BACKGROUND: Recombinant human C1 Inhibitor (rhC1INH) has been approved in Europe for the treatment of acute hereditary angioedema attacks. The efficacy of rhC1INH was demonstrated in 2 randomized-controlled trials. Open-label extension studies, where patients could be treated for subsequent HAE atta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Reshef, Avner, Riedl, Marc, Moldovan, Dumitru, Lockey, Richard F., Montinaro, Vincenzo, Suez, Daniel, Relan, Anurag, Cicardi, Marco, Zuraw, Bruce
Format: Artigo
Sprog:Inglês
Udgivet: World Allergy Organization Journal 2012
Fag:
Abstracts of the XXII World Allergy Congress
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513148/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411830.69753.fb
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker